Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from JBM (Healthcare) Ltd. ( (HK:2161) ).
JBM (Healthcare) Limited has announced that its board of directors will meet on November 17, 2025, to review and approve the interim results for the six months ending September 30, 2025. The meeting will also consider the recommendation of an interim dividend and address any other business matters, potentially impacting the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:2161) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on JBM (Healthcare) Ltd. stock, see the HK:2161 Stock Forecast page.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited is a company incorporated in the Cayman Islands, operating within the healthcare industry. It focuses on providing healthcare products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
Average Trading Volume: 725,061
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.45B
For an in-depth examination of 2161 stock, go to TipRanks’ Overview page.